These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Intratypic differentiation of poliovirus strains, with special reference to vaccination reactions following oral administration]. Thraenhart O; Kuwert E Zentralbl Bakteriol Orig A; 1972 Jul; 221(2):143-56. PubMed ID: 4146494 [No Abstract] [Full Text] [Related]
3. Detection of polioviruses in human cerebrospinal fluid. Rocchi G; Andreoni G Arch Gesamte Virusforsch; 1968; 25(3):359-62. PubMed ID: 4303676 [No Abstract] [Full Text] [Related]
4. Paralytic poliomyelitis caused by a vaccine-derived polio virus in an antibody-deficient Argentinean child. Hidalgo S; García Erro M; Cisterna D; Freire MC Pediatr Infect Dis J; 2003 Jun; 22(6):570-2. PubMed ID: 12828159 [TBL] [Abstract][Full Text] [Related]
6. Neurologic complications associated with oral poliovirus vaccine and genomic variability of the vaccine strains after multiplication in humans. Friedrich F Acta Virol; 1998 Jun; 42(3):187-94. PubMed ID: 9842449 [TBL] [Abstract][Full Text] [Related]
7. [Clinical and laboratory diagnosis of herpes type diseases]. Mikhaĭlenko AA; Kuznetsova EE; Iovlev VI Vrach Delo; 1980 May; (5):101-6. PubMed ID: 7395152 [No Abstract] [Full Text] [Related]
13. Characterisation of two different types of poliovirus isolated from a patient. Tsilimigras CW; Schoub BD J Infect; 1988 Sep; 17(2):159-61. PubMed ID: 2846704 [TBL] [Abstract][Full Text] [Related]
14. Laboratory surveillance for wild and vaccine-derived polioviruses, January 2002-June 2003. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2003 Sep; 52(38):913-6. PubMed ID: 14508441 [TBL] [Abstract][Full Text] [Related]
15. High variability in viral load in cerebrospinal fluid from patients with herpes simplex and varicella-zoster infections of the central nervous system. Růzek D; Piskunova N; Zampachová E Clin Microbiol Infect; 2007 Dec; 13(12):1217-9. PubMed ID: 17953699 [TBL] [Abstract][Full Text] [Related]
16. [Vaccination against poliomyelitis]. Cellesi C; Rossolini A Pediatr Med Chir; 1984; 6(1):13-5. PubMed ID: 6099548 [TBL] [Abstract][Full Text] [Related]
17. Reflections on the qualitative and quantitative aspects of neurovirulence of different polioviruses. Sabin AB Dev Biol Stand; 1993; 78():3-7. PubMed ID: 8388830 [No Abstract] [Full Text] [Related]
18. Ala67Thr mutation in the poliovirus receptor CD155 is a potential risk factor for vaccine and wild-type paralytic poliomyelitis. Kindberg E; Ax C; Fiore L; Svensson L J Med Virol; 2009 May; 81(5):933-6. PubMed ID: 19319949 [TBL] [Abstract][Full Text] [Related]
19. [Possibility of diseases affecting the central nervous system caused by vaccine strains of poliovirus, type 3]. Golub NF; Bogdanov IL; Vashchenko MA Zh Mikrobiol Epidemiol Immunobiol; 1972 May; 49(5):134-6. PubMed ID: 5037754 [No Abstract] [Full Text] [Related]